Stockreport

CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF  - Wholly-Owned anti-PD-L1 and anti-CD166 Programs Entering Phase 2 Studies – - Partnered Clinical Programs Advancing - - Multiple Updates Anticipated Across Port [Read more]